Back
Recursion Pharmaceuticals Vs. Actinium Pharmaceuticals Industry Stock Comparison
Buy
74
RXRX
Recursion Pharmaceuticals
Last Price:
9.42
Seasonality Move:
66.82%
Buy
53
ATNM
Actinium Pharmaceuticals
Last Price:
9.75
Seasonality Move:
-2.01%
Buy
74
Recursion Pharmaceuticals (RXRX)
is a Buy
Is Recursion Pharmaceuticals a Buy, Sell or Hold?
- The current Recursion Pharmaceuticals [RXRX] share price is $9.42. The Score for RXRX is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- RXRX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Actinium Pharmaceuticals (ATNM)
is a Buy
Is Actinium Pharmaceuticals a Buy, Sell or Hold?
- The current Actinium Pharmaceuticals [ATNM] share price is $9.80. The Score for ATNM is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- ATNM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RXRX Stock Price Chart
What is Recursion Pharmaceuticals's stock price today?
-
The Recursion Pharmaceuticals share price today is $9.42
The current trend is moderately bullish and RXRX is experiencing slight buying pressure.
ATNM Stock Price Chart
What is Actinium Pharmaceuticals's stock price today?
-
The Actinium Pharmaceuticals share price today is $9.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATNM is experiencing slight buying pressure.
RXRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 56.02 | Buy |
| Chaikin Money Flow: | 1036064 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.64 - 9.22) | Buy |
| Bollinger Bands (100): | (8.49 - 11.93) | Sell |
ATNM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.5 | Buy |
| Relative Strength Index (14 RSI): | 66.22 | Buy |
| Chaikin Money Flow: | 78855 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.1 - 9.24) | Buy |
| Bollinger Bands (100): | (5.53 - 8.61) | Buy |
RXRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.29 | Buy |
| 20-day SMA: | 8.66 | Buy |
| 50-day SMA: | 9.2 | Buy |
| 200-day SMA: | 8.98 | Buy |
| 8-day EMA: | 9.35 | Buy |
| 20-day EMA: | 8.98 | Buy |
| 50-day EMA: | 9.23 | Buy |
| 200-day EMA: | 9.26 | Buy |
ATNM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.31 | Buy |
| 20-day SMA: | 8.37 | Buy |
| 50-day SMA: | 8.18 | Buy |
| 200-day SMA: | 6.36 | Buy |
| 8-day EMA: | 9.38 | Buy |
| 20-day EMA: | 8.78 | Buy |
| 50-day EMA: | 8.14 | Buy |
| 200-day EMA: | 7.12 | Buy |
Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.25 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.15 per share.
Actinium Pharmaceuticals Earnings Growth & ATNM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.46 per share, an increase this year of $0.45 per share, and an increase next year of $1.05 per share.
Recursion Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Actinium Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||